Table 2.
Risk Factors and Diseases | |
---|---|
Genetic predisposition | nitric oxide synthase gene polymorphism |
gene polymorphisms of the renin–angiotensin–aldosterone system and aldosterone synthase genes | |
single-nucleotide polymorphism of ATP2B1 (ATPase Plasma Membrane Ca2+ Transporting 1) familial hypercholesterolemia | |
Perinatal factors | conception by assisted reproductive technology maternal hypercholesterolemia, obesity, metabolic syndrome placental insufficiency being small for gestational age preterm delivery formula-feeding |
Environmental factors | lack of exercise |
poor nutrition | |
exposure to phthalates | |
lower socioeconomic status | |
Psycho-emotional factors | anxiety irritability predisposition to depressive reactions |
Weight status | Underweight Overweight Obese |
Immunosuppressive treatment | cyclosporine tacrolimus |
Dialysis | |
Hypovitaminosis | D and B12 |
Hyperhomocysteinemia | |
Kidney diseases | chronic kidney disease hydronephrosis glomerulonephritis pyelonephritis lower urinary tract infections |
Arterial hypertension | essential and secondary |
Obstructive sleep apnea | |
Diabetes mellitus | type 1 and 2 |
Metabolic syndrome |